These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 26880993)

  • 41. Integration-free reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) without viral vectors, recombinant DNA, and genetic modification.
    Heng BC; Fussenegger M
    Methods Mol Biol; 2014; 1151():75-94. PubMed ID: 24838880
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Induced pluripotent stem cells: progress and future perspectives in the stem cell world.
    Rezanejad H; Matin MM
    Cell Reprogram; 2012 Dec; 14(6):459-70. PubMed ID: 23035654
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Induced Pluripotent Stem Cells and Induced Pluripotent Cancer Cells in Cancer Disease Modeling.
    Zhu D; Kong CSL; Gingold JA; Zhao R; Lee DF
    Adv Exp Med Biol; 2018; 1119():169-183. PubMed ID: 30069853
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transactivator protein: An alternative for delivery of recombinant proteins for safer reprogramming of induced Pluripotent Stem Cell.
    Nordin F; Ahmad RNR; Farzaneh F
    Virus Res; 2017 May; 235():106-114. PubMed ID: 28408207
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Advances in microRNA-mediated reprogramming technology.
    Kuo CH; Ying SY
    Stem Cells Int; 2012; 2012():823709. PubMed ID: 22550519
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Patient-derived induced pluripotent stem cells for models of cancer and cancer stem cell research.
    Chao HM; Chern E
    J Formos Med Assoc; 2018 Dec; 117(12):1046-1057. PubMed ID: 30172452
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Induced pluripotent stem cells and their use in cardiac and neural regenerative medicine.
    Skalova S; Svadlakova T; Shaikh Qureshi WM; Dev K; Mokry J
    Int J Mol Sci; 2015 Feb; 16(2):4043-67. PubMed ID: 25689424
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Twenty years of embryonic stem cell research in farm animals.
    Blomberg LA; Telugu BP
    Reprod Domest Anim; 2012 Aug; 47 Suppl 4():80-5. PubMed ID: 22827354
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Methods of induced pluripotent stem cells for clinical application.
    Seki T; Fukuda K
    World J Stem Cells; 2015 Jan; 7(1):116-25. PubMed ID: 25621111
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An insight into non-integrative gene delivery approaches to generate transgene-free induced pluripotent stem cells.
    Haridhasapavalan KK; Borgohain MP; Dey C; Saha B; Narayan G; Kumar S; Thummer RP
    Gene; 2019 Feb; 686():146-159. PubMed ID: 30472380
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gas5 is an essential lncRNA regulator for self-renewal and pluripotency of mouse embryonic stem cells and induced pluripotent stem cells.
    Tu J; Tian G; Cheung HH; Wei W; Lee TL
    Stem Cell Res Ther; 2018 Mar; 9(1):71. PubMed ID: 29562912
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparing ESC and iPSC-Based Models for Human Genetic Disorders.
    Halevy T; Urbach A
    J Clin Med; 2014 Oct; 3(4):1146-62. PubMed ID: 26237596
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pluripotent stem cell derivation and differentiation toward cardiac muscle: novel techniques and advances in patent literature.
    Quattrocelli M; Thorrez L; Sampaolesi M
    Recent Pat Drug Deliv Formul; 2013 Apr; 7(1):18-28. PubMed ID: 22974171
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The application of induced pluripotent stem cells for bone regeneration: current progress and prospects.
    Teng S; Liu C; Krettek C; Jagodzinski M
    Tissue Eng Part B Rev; 2014 Aug; 20(4):328-39. PubMed ID: 24102431
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Induced Pluripotent Stem Cells Reprogrammed with Three Inhibitors Show Accelerated Differentiation Potentials with High Levels of 2-Cell Stage Marker Expression.
    Nishihara K; Shiga T; Nakamura E; Akiyama T; Sasaki T; Suzuki S; Ko MSH; Tada N; Okano H; Akamatsu W
    Stem Cell Reports; 2019 Feb; 12(2):305-318. PubMed ID: 30713040
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epigenetic regulation of somatic cell reprogramming.
    Wang Y; Bi Y; Gao S
    Curr Opin Genet Dev; 2017 Oct; 46():156-163. PubMed ID: 28823984
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Toward Cardiac Regeneration: Combination of Pluripotent Stem Cell-Based Therapies and Bioengineering Strategies.
    Mazzola M; Di Pasquale E
    Front Bioeng Biotechnol; 2020; 8():455. PubMed ID: 32528940
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterizing Pluripotent Stem Cells Using the TaqMan® hPSC Scorecard(TM) Panel.
    Fergus J; Quintanilla R; Lakshmipathy U
    Methods Mol Biol; 2016; 1307():25-37. PubMed ID: 25138722
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MicroRNAs: Important Regulators of Induced Pluripotent Stem Cell Generation and Differentiation.
    Zeng ZL; Lin XL; Tan LL; Liu YM; Qu K; Wang Z
    Stem Cell Rev Rep; 2018 Feb; 14(1):71-81. PubMed ID: 29143183
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro gametogenesis from embryonic stem cells in livestock species: recent advances, opportunities, and challenges to overcome.
    Botigelli RC; Guiltinan C; Arcanjo RB; Denicol AC
    J Anim Sci; 2023 Jan; 101():. PubMed ID: 37140043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.